Article Test

Home  >  Medical Research Archives  >  Issue 149  > Review of Pharmacotherapy in the Treatment of the Catatonic Syndrome: First-Line, Adjunctive/Combination and Novel Options
Published in the Medical Research Archives
Nov 2016 Issue

Review of Pharmacotherapy in the Treatment of the Catatonic Syndrome: First-Line, Adjunctive/Combination and Novel Options

Published on Nov 17, 2016

DOI 

Abstract

 

Catatonia is a clinical syndrome characterized by a range of psychomotor abnormalities that occur in the context of a wide variety of both psychiatric and medical conditions.  It occurs in affective, psychotic, autistic, developmental and medical disorders. Catatonia may present with unusual stereotypies and medical comorbidities. Despite these various etiologies, treatment has been convergent on the gamma aminobutyric acid agonists (i.e., benzodiazepines), and glutamate antagonists, corresponding with the known pathophysiology on this syndrome. Treatment refractory and emergent cases are often referred to electroconvulsive therapy. The focus of this manuscript will be to review these known treatments in montherapy, adjunctive, combined, and potential novel pharmacotherapy.

Author info

David Spiegel

Have an article to submit?

Submission Guidelines

Submit a manuscript

Become a member

Call for papers

Have a manuscript to publish in the society's journal?